Regulatory actions for Nov. 5, 2019 Nov. 5, 2019 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Regulatory actions for Nov. 5, 2019 Nov. 5, 2019 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Regulatory actions for Nov. 4, 2019 Nov. 4, 2019 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Regulatory actions for Nov. 1, 2019 Nov. 1, 2019 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Regulatory actions for Nov. 1, 2019 Nov. 1, 2019 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Regulatory actions for Oct. 31, 2019 Oct. 31, 2019 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Product regulatory actions for October 30, 2019 Oct. 31, 2019 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
New device joins forces with patient network to combat TRS Oct. 31, 2019 By David Godkin TORONTO – Health Canada has granted a medical license to Toronto-based pharmaceuticals company Hls Therapeutics Inc. for a device that simplifies blood monitoring for patients suffering from treatment-resistant schizophrenia (TRS).Read More
Regulatory actions for Oct. 30, 2019 Oct. 30, 2019 Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
Product regulatory actions for October 29, 2019 Oct. 30, 2019 Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations.Read More
RSS